Treatment of supraspinous bursitis by use of debridement in standing horses: 10 cases (1968-1999).
OBJECTIVE
To evaluate efficacy of debridement for treatment of supraspinous bursitis in horses and to evaluate the outcome.


METHODS
Retrospective study.


METHODS
10 horses with clinical signs of supraspinous bursitis.


METHODS
Medical records were reviewed for signalment, anamnesis, results of physical and radiographic examination, microbial culture results of supraspinous bursa tissue or exudate, Brucella abortus titers, type of antimicrobial and anti-inflammatory therapies, surgical technique, complications of the surgical procedure, and findings on histologic examination of excised nuchal ligament and bursal tissue. Telephone follow-up with owners, trainers, or referring veterinarians was performed.


RESULTS
The described surgical technique was effective in resolving drainage from the supraspinous bursal region in 5 of 6 horses available for long-term follow-up. The most common complication following surgery was the development of purulent wound drainage. Two horses required multiple surgeries to resolve clinical signs of supraspinous bursitis. The most common organism isolated from the supraspinous bursa was beta-hemolytic Streptococcus spp. All horses were discharged from the hospital and long-term follow-up was available for 6 horses. All 6 horses could be used for their intended use.


CONCLUSIONS
Debridement in standing horses is an effective method of resolving clinical signs of supraspinous bursitis.
Hawkins
J F
JF
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907-1248, USA.
Fessler
J F
JF
D000818:Animals; D002062:Bursitis / Q000601:surgery / Q000662:veterinary*; D003646:Debridement / Q000662:veterinary*; D004322:Drainage / Q000662:veterinary; D005260:Female; D005500:Follow-Up Studies; D006734:Horse Diseases / Q000601:surgery*; D006736:Horses; D008297:Male; D011183:Postoperative Complications / Q000662:veterinary; D012189:Retrospective Studies; D016896:Treatment Outcome